Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001053472 | SCV001217736 | likely benign | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71 | 2024-12-31 | criteria provided, single submitter | clinical testing | |
| New York Genome Center | RCV001053472 | SCV002764474 | uncertain significance | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71 | 2021-12-12 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV002553321 | SCV003195089 | uncertain significance | not provided | 2023-01-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
| Dept Of Ophthalmology, |
RCV003890196 | SCV004705271 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
| Breakthrough Genomics, |
RCV002553321 | SCV005187514 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
| Fulgent Genetics, |
RCV005021380 | SCV005651460 | uncertain significance | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71; Bardet-Biedl syndrome 20 | 2024-04-22 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV004553592 | SCV004750470 | likely benign | IFT172-related disorder | 2022-02-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |